Younis, A., Eskenazi, D., Goldkorn, R., Leor, J., Naftali-Shani, N., Fisman, E. Z., . . . Klempfner, R. (2017). The addition of vildagliptin to metformin prevents the elevation of interleukin 1ß in patients with type 2 diabetes and coronary artery disease: A prospective, randomized, open-label study. Cardiovasc Diabetol.
シカゴスタイル引用形Younis, Arwa, Dana Eskenazi, Ronen Goldkorn, Jonathan Leor, Nili Naftali-Shani, Enrique Z. Fisman, Alexander Tenenbaum, Ilan Goldenberg, , Robert Klempfner. "The Addition of Vildagliptin to Metformin Prevents the Elevation of Interleukin 1ß in Patients With Type 2 Diabetes and Coronary Artery Disease: A Prospective, Randomized, Open-label Study." Cardiovasc Diabetol 2017.
MLA引用形式Younis, Arwa, et al. "The Addition of Vildagliptin to Metformin Prevents the Elevation of Interleukin 1ß in Patients With Type 2 Diabetes and Coronary Artery Disease: A Prospective, Randomized, Open-label Study." Cardiovasc Diabetol 2017.